Revance Therapeutics, Inc. (RVNC)

NASDAQ: RVNC · IEX Real-Time Price · USD

3.570

-0.090 (-2.46%)

At close: Apr 24, 2024, 4:00 PM

3.710

+0.140 (3.92%)

After-hours: Apr 24, 2024, 5:10 PM EDT

Revance Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-323.99	-356.42	-281.31	-282.09	-159.43	-142.57	-120.59	-89.27	-73.48	-62.92	Upgrade
Depreciation & Amortization	13.69	39.15	19.85	10.25	2.91	1.73	1.47	1.45	2	2.05	Upgrade
Share-Based Compensation	47.81	52.34	43.43	36.45	17.92	16.27	13.23	11.95	12.39	6.53	Upgrade
Other Operating Activities	45.91	71.39	-3.52	56.88	32.44	20.32	10.55	16.05	3.42	-0.74	Upgrade
Operating Cash Flow	-216.58	-193.55	-221.54	-178.5	-106.16	-104.25	-95.34	-59.83	-55.67	-55.07	Upgrade
Capital Expenditures	-6.89	-3.21	-10.38	-4.1	-3.23	-5.55	-2.53	-1.67	-3.33	-6.98	Upgrade
Acquisitions	0	0	0	-0.82	0	0	0	0	0	0	Upgrade
Change in Investments	116.63	-135.59	-19.29	17.17	-14.36	-101.48	121.42	-72.03	-53.09	0	Upgrade
Other Investing Activities	-	-	-	-0.12	-	-	-0.1	-1.8	-	-	Upgrade
Investing Cash Flow	109.74	-138.8	-29.67	12.13	-17.59	-107.03	118.79	-75.5	-56.42	-6.98	Upgrade
Share Issuance / Repurchase	115.47	252.83	38.39	90.84	223.78	5.29	200.8	1.65	139	236.32	Upgrade
Debt Issued / Paid	29.31	85.01	-0.34	277.95	0	-0.93	-3.64	-3.54	-5.25	-5.79	Upgrade
Other Financing Activities	-8.22	-6.15	-8.19	-37.31	-2.12	-2.58	-1.22	-0.75	8.84	-1.44	Upgrade
Financing Cash Flow	136.57	331.69	29.87	331.48	221.66	1.78	195.94	-2.64	142.59	229.09	Upgrade
Net Cash Flow	29.73	-0.65	-221.33	165.11	97.9	-209.49	219.39	-137.97	30.51	167.04	Upgrade
Free Cash Flow	-223.46	-196.76	-231.91	-182.6	-109.39	-109.8	-97.87	-61.5	-59	-62.05	Upgrade
Free Cash Flow Margin	-95.48%	-148.42%	-298.10%	-1191.52%	-26486.92%	-2944.38%	-37353.82%	-20498.33%	-19665.67%	-16200.52%	Upgrade
Free Cash Flow Per Share	-2.64	-2.71	-3.44	-3.15	-2.52	-3.04	-3.25	-2.19	-2.42	-3.20	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).